Newstral
Article
San Jose Mercury News on 2018-03-07 07:51
23andMe gets FDA approval to report breast cancer risk without a doctor
Related news
- 23andMe gets FDA approval for at-home breast cancer risk testwtnh.com
- Test risk of breast cancer from home with new FDA-approved DNA kit by 23andMeKING 5
- 23andMe Is Back in the Genetic Testing Business With FDA Approvalgizmodo.com
- 23andMe reboots genetic health testing, now with FDA approvalArs Technica
- 23andMe gets FDA clearance for prostate cancer risk testThe Verge
- 23andMe gets FDA green light for cancer risk testTechCrunch
- No doctor required: 23andMe cleared by FDA for at-home DNA testsThe Verge
- UCLA breast cancer research leads to Ibrance drug FDA approvaldailybruin.com
- Pfizer breast cancer drug gets early FDA approvalabc3340.com
- BFDA Grants Full Approval to Gilead Breast Cancer Drugbarrons.com
- MFDA approves direct-to-consumer breast cancer risk reportmasslive.com
- VWhat You Can Learn About Your Breast Cancer Risk From 23andMe vitals.lifehacker.com
- 23andMe Will Now Test for BRCA Breast-Cancer GenesThe Atlantic
- Santa Fe doctor prescribed birth control without FDA approvalKRQE News 13
- FDA to revoke approval of carbadox on cancer risktriblive.com
- FDA grants 23andMe approval to test for rare genetic conditionThe Verge
- 23andMe gets FDA approval for consumer cancer teststaradvertiser.com
- 23andMe Will Let You Test For Risk of Breast CancerNBC Bay Area